Repligen Corp (RGEN) SEC Filings — 2024
24 SEC filings for Repligen Corp (RGEN) in 2024.
Filings
- Repligen Corp. Amends 2023 10-K Filing — 10-K/A · Nov 18, 2024
- Repligen Corp SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Repligen Corp SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Repligen Corp Files 8-K on Financials — 8-K · Nov 12, 2024
- Repligen Corp SC 13G/A Filing — SC 13G/A · Oct 23, 2024
- Repligen Corp. Restates Financials Amid Investigation — 8-K · Sep 18, 2024
- Repligen Corp SC 13G/A Filing — SC 13G/A · Sep 10, 2024
- Repligen Corp Files 8-K on Operations and Financials — 8-K · Jul 30, 2024
- Repligen Corp. Files Q2 2024 10-Q — 10-Q · Jul 30, 2024
- Repligen Acquires Validus Therapeutics for $100M+ — 8-K · Jul 15, 2024
- Repligen Corp Appoints New CFO, Elects Directors — 8-K · Jun 14, 2024
- Repligen to Acquire Izon Science for $113M — 8-K · Jun 13, 2024
- Repligen Corp Files 8-K on Shareholder Vote Matters — 8-K · May 17, 2024
- Repligen Corp Files Proxy Statement Supplement — DEFA14A · May 3, 2024
- Repligen Corp Files 8-K on Financials — 8-K · May 1, 2024
- Repligen Corp Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 1, 2024
- Repligen Corp. Files Definitive Proxy Statement (DEF 14A) — DEF 14A · Apr 1, 2024
- Repligen Corp Elects Dr. Jonathan M. Rothberg to Board — 8-K · Mar 19, 2024
- Repligen Corp. Files 2023 Annual Report on Form 10-K — 10-K · Feb 22, 2024
- Repligen Files 8-K on Financial Condition and Operations — 8-K · Feb 21, 2024
- Repligen Corp SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Vanguard Discloses 12.0% Stake in Repligen Corp — SC 13G/A · Feb 13, 2024
- Eddleman Living Trust Maintains 2.7M Share Stake in Repligen — SC 13G/A · Feb 6, 2024
- BlackRock Amends Repligen Stake, Signals Continued Confidence — SC 13G/A · Jan 23, 2024